skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:063927/0840   Pages: 15
Recorded: 06/08/2023
Attorney Dkt #:007170-00003
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 19
1
Patent #:
10584357
Issue Dt:
03/10/2020
Application #:
16552714
Filing Dt:
08/27/2019
Publication #:
US20190376091
Pub Dt:
12/12/2019
Title:
PRIMARY CELL GENE EDITING
2
Patent #:
10550406
Issue Dt:
02/04/2020
Application #:
16552786
Filing Dt:
08/27/2019
Publication #:
US20190376086
Pub Dt:
12/12/2019
Title:
PRIMARY CELL GENE EDITING
3
Patent #:
10875905
Issue Dt:
12/29/2020
Application #:
16679025
Filing Dt:
11/08/2019
Publication #:
US20200062819
Pub Dt:
02/27/2020
Title:
PEPTIDE-MHC COMPACTS
4
Patent #:
10711283
Issue Dt:
07/14/2020
Application #:
16782450
Filing Dt:
02/05/2020
Publication #:
US20200181650
Pub Dt:
06/11/2020
Title:
PRIMARY CELL GENE EDITING
5
Patent #:
10676758
Issue Dt:
06/09/2020
Application #:
16782815
Filing Dt:
02/05/2020
Publication #:
US20200165634
Pub Dt:
05/28/2020
Title:
PRIMARY CELL GENE EDITING
6
Patent #:
11513113
Issue Dt:
11/29/2022
Application #:
16788745
Filing Dt:
02/12/2020
Publication #:
US20200256849
Pub Dt:
08/13/2020
Title:
COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ANTIGEN SPECIFIC T CELLS
7
Patent #:
NONE
Issue Dt:
Application #:
16893166
Filing Dt:
06/04/2020
Publication #:
US20200299730
Pub Dt:
09/24/2020
Title:
PRIMARY CELL GENE EDITING
8
Patent #:
NONE
Issue Dt:
Application #:
16951925
Filing Dt:
11/18/2020
Publication #:
US20210070834
Pub Dt:
03/11/2021
Title:
PEPTIDE-MHC COMPACTS
9
Patent #:
NONE
Issue Dt:
Application #:
17003544
Filing Dt:
08/26/2020
Publication #:
US20210062248
Pub Dt:
03/04/2021
Title:
METHODS OF PERFORMING GUIDE-SEQ ON PRIMARY HUMAN T CELLS
10
Patent #:
NONE
Issue Dt:
Application #:
17067101
Filing Dt:
10/09/2020
Publication #:
US20210106621
Pub Dt:
04/15/2021
Title:
METHOD OF TREATING IMMUNOTHERAPY NON-RESPONDERS WITH AN AUTOLOGOUS CELL THERAPY
11
Patent #:
NONE
Issue Dt:
Application #:
17099140
Filing Dt:
11/16/2020
Publication #:
US20210085720
Pub Dt:
03/25/2021
Title:
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TET2 ENGINEERED T CELL THERAPY
12
Patent #:
NONE
Issue Dt:
Application #:
17099192
Filing Dt:
11/16/2020
Publication #:
US20210205363
Pub Dt:
07/08/2021
Title:
METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS T CELL IMMUNOTHERAPY
13
Patent #:
11304978
Issue Dt:
04/19/2022
Application #:
17100223
Filing Dt:
11/20/2020
Publication #:
US20210085721
Pub Dt:
03/25/2021
Title:
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A CD8 ENGINEERED T CELL THERAPY
14
Patent #:
NONE
Issue Dt:
Application #:
17202067
Filing Dt:
03/15/2021
Publication #:
US20210230544
Pub Dt:
07/29/2021
Title:
ANTIGEN SPECIFIC TCR IDENTIFICATION USING SINGLE-CELL SORTING
15
Patent #:
NONE
Issue Dt:
Application #:
17400974
Filing Dt:
08/12/2021
Publication #:
US20210395783
Pub Dt:
12/23/2021
Title:
PRIMARY CELL GENE EDITING
16
Patent #:
NONE
Issue Dt:
Application #:
17487411
Filing Dt:
09/28/2021
Publication #:
US20220010274
Pub Dt:
01/13/2022
Title:
PERSONALIZED NEOANTIGEN-SPECIFIC ADOPTIVE CELL THERAPIES
17
Patent #:
NONE
Issue Dt:
Application #:
17691565
Filing Dt:
03/10/2022
Publication #:
US20220193139
Pub Dt:
06/23/2022
Title:
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A CD8 ENGINEERED T CELL THERAPY
18
Patent #:
NONE
Issue Dt:
Application #:
18049114
Filing Dt:
10/24/2022
Publication #:
US20230136076
Pub Dt:
05/04/2023
Title:
METHODS OF DETERMINING GENE EDITING EFICIENCIES IN CELLS
19
Patent #:
NONE
Issue Dt:
Application #:
18050715
Filing Dt:
10/28/2022
Publication #:
US20230194504
Pub Dt:
06/22/2023
Title:
COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ANTIGEN SPECIFIC T CELLS
Assignor
1
PACT PHARMA, INC.
Exec Dt:
06/06/2023
Assignee
1
ADOC SSF, LLC
2 CORPORATE DRIVE
2ND FLOOR
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondence name and address
KATELYN JAMES C/O FRIED FRANK ET AL
1 NEW YORK PLAZA
27TH FLOOR
NEW YORK, NY 10004

Search Results as of: 09/22/2024 03:11 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT